NewGenIvf (NIVF) Short-term Investments (2024 - 2025)

NewGenIvf (NIVF) posted quarterly Short-term Investments of $34987.0 for Q4 2025, down 96.5% YoY from $1.0 million in Q4 2024, and down 100.0% sequentially from $2674.0 billion in Q3 2025.

NewGenIvf (NIVF) Short-term Investments (2024 - 2025) Analysis & Trends

NewGenIvf has disclosed Short-term Investments across 2 years of filings, most recently posting $34987.0 for Q4 2025.

  • In Q4 2025, Short-term Investments fell 96.5% year-over-year to $34987.0; the TTM figure through Dec 2025 stood at $34987.0 (down 96.5% YoY), while the FY2025 annual figure was $34987.0, down 96.5% from the prior year.
  • Short-term Investments eased to $34987.0 in Q4 2025, from $2674.0 billion in the prior quarter.
  • Over the last five years, Short-term Investments for NIVF reached as high as $2674.0 billion in Q3 2025 and fell as low as $34987.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 87.94 Bn 90.32 Bn 16.26 Bn
2 Chemed 18.08 Bn 18.07 Bn 215.76 Mn
3 Tenet Healthcare 16.59 Bn 15.76 Bn 4.41 Bn
4 Davita 15.37 Bn 16.23 Bn 1.07 Bn
5 Encompass Health 10.07 Bn 10.70 Bn 1.34 Bn
6 Ensign 9.52 Bn 8.93 Bn 293.37 Mn
7 Universal Health Services 9.19 Bn 9.15 Bn 3.21 Bn
8 Pacs 6.96 Bn 6.72 Bn 345.96 Mn
9 Ww International 6.14 Bn 5.98 Bn -149.29 Mn
10 NewGenIvf 25,304.95 -1.41 Mn 524,025.00

Historic Data

Download Data
DateValue
Dec 31, 2025 34,987.00
Sep 30, 2025 2,674.04 Bn
Dec 31, 2024 1.00 Mn